Cite
HARVARD Citation
Qin, S. et al. (2022). Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration‐Resistant Prostate Cancer. Clinical pharmacology & therapeutics. 111 (6), pp. 1296-1306. [Online].